Tenderwize
Back to tender search

Tamsulosin and solifenacin discount contracts

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2028 · 497 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tamsulosin und Solifenacin, ATC G04CA53

61/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

61 / 100

Complexity

62 / 100

Risk factors

No value, volume, demand forecast, or guaranteed business is stated, so the commercial opportunity cannot be priced or...

The AOK may replace the open-house agreements with exclusive rebate contracts, causing existing open-house contracts to...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 31, 2028

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Sections 130a(8) and 130c(1) SGB V.
  • Supply of medicines containing the active ingredients Tamsulosin and Solifenacin, ATC G04CA53.
Show full summary

Open-house, non-exclusive pharmaceutical rebate contracts offered by AOK Rheinland-Pfalz/Saarland for medicines containing Tamsulosin and Solifenacin, ATC G04CA53. All interested pharmaceutical companies may join without a selection decision, under uniform non-negotiable terms. Contracts may start on the first day of a month from 1 June 2026, run for a maximum of 24 months, and may be automatically terminated if exclusive rebate contracts replace them. No contract value or guaranteed volume is stated. Procurement documents were not analyzed; access requires registration and release through the DTVP project room.

Risks

No value, volume, demand forecast, or guaranteed business is stated, so the commercial opportunity cannot be priced or...

The AOK may replace the open-house agreements with exclusive rebate contracts, causing existing open-house contracts to...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only pharmaceutical companies may participate as potential contract partners.
  • Medicines must be approved and marketable in Germany.
  • Listing as marketable in the Lauer-Taxe is accepted as evidence where applicable.

Buyer

Lots (1)

LOT-0001

Tamsulosin and Solifenacin Rebate Contracts

Open-house rebate agreements for pharmaceutical companies supplying approved and marketable medicines containing Tamsulosin and Solifenacin, ATC G04CA53. Contracts are non-exclusive, use uniform conditions, permit no individual negotiations, and exclude medicines on the BfArM list of children's medicines under Section 35(5a) SGB V.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2028

Procurement Details

Publication date
09 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
244895-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy